Arca
Skip to content
Tools
Tools

Duane Reade TRUEtrack monitor kit

Recall Z-1140-2013, part of FDA recall event 64499. See Nipro Diagnostics's company page.

Nipro Diagnostics, Inc. started this Class II device recall on Feb 25, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 8, 2013.

  • Classification: Class II
  • Started: Feb 25, 2013
  • Status: Terminated

Why It Was Recalled

Class II

Meter kit outer boxes containing 10 ct. test strips state incorrect storage temperature range.

Record

Product
Duane Reade TRUEtrack monitor kit, UPC# 6 39194 01679 7 Part # A4006-81 The TRUEtrack Blood Glucose System is intended for the quantitative determination of glucose in human whole blood taken from finger or forearm. The System is intended to be used to assist the patient and healthcare professional in the management of diabetes.
Quantity
1,627 Kits
Lots and codes
Finished Good (FG) Kit Lot# KL01009-3TI, TRUEtrack Test Strip Lot# RL3435; FG Kit Lot# KL01009-12TI, TRUEtrack Test Strip Lot# RL3435; FG Kit Lot# KL01233-4TI, TRUEtrack Test Strip Lot# RL3476; FG Kit Lot# KM0548TI, TRUEtrack Test Strip Lot# RM3547; FG Kit Lot# KM0645TI, TRUEtrack Test Strip Lot# RM3562; FG Lot# KM0692TI, TRUEtrack Test Strip Lot# RM3562.
Distribution
Nationwide Distribution only in NY.
Recalling firm
Nipro Diagnostics, Inc., Ft Lauderdale, FL, United States
How the firm notified
Letter
FDA classified
Apr 18, 2013

Nipro Diagnostics, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.